Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Indian J Dermatol Venereol Leprol ; 2018 Nov; 84(6): 678-684
Article | IMSEAR | ID: sea-192433

ABSTRACT

Background: Recurrent and clinically unresponsive dermatophytosis is being increasingly encountered in our country. It runs a protracted course with exacerbations and remissions. However, there is little information regarding the extent of the problem and the characteristics of recurrent dermatophytosis in published literature. Aims: We sought to determine the prevalence, risk factors and clinical patterns of recurrent dermatophytosis in our institution. We also investigated the causative dermatophyte species and antifungal susceptibility patterns in these species. Methods: One hundred and fifty patients with recurrent dermatophytosis attending the outpatient department of the Postgraduate Institute of Medical Education and Research, Chandigarh, India were enrolled in the study conducted from January 2015 to December 2015. A detailed history was obtained in all patients, who were then subjected to a clinical examination and investigations including a wet preparation for direct microscopic examination, fungal culture and antifungal susceptibility tests. Results: Recurrent dermatophytosis was seen in 9.3% of all patients with dermatophytosis in our study. Trichophyton mentagrophytes was the most common species identified (36 patients, 40%) samples followed by T. rubrum (29 patients, 32.2%). In-vitro antifungal susceptibility testing showed that the range of minimum inhibitory concentrations (MIC) on was lowest for itraconazole (0.015–1), followed by terbinafine (0.015–16), fluconazole (0.03–32) and griseofulvin (0.5–128) in increasing order. Limitation: A limitation of this study was the absence of a suitable control group (eg. patients with first episode of typical tinea). Conclusion: Recurrence of dermatophytosis was not explainable on the basis of a high (MIC) alone. Misuse of topical corticosteroids, a high number of familial contacts, poor compliance to treatment over periods of years, and various host factors, seem to have all contributed to this outbreak of dermatophytosis in India.

2.
Indian J Dermatol Venereol Leprol ; 2014 Jan-Feb; 80(1): 46-50
Article in English | IMSEAR | ID: sea-154748

ABSTRACT

IgG/IgA pemphigus is an extremely rare subset of pemphigus, showing anti-keratinocyte cell surface antibodies of both IgG and IgA classes. Herein, we describe a unique case of IgG/IgA pemphigus with clinical features of edematous erythema and peripheral vesiculopustules. Histopathology showed the presence of subcorneal pustules and acantholytic blisters in the mid-epidermis with neutrophilic infiltration and eosinophilic spongiosis. Direct immunofluorescence of perilesional skin showed both IgG and IgA deposits to keratinocyte cell surfaces and unusual granular deposits of IgG, IgM, and C3 along basement membrane zone. On enzyme linked immunosorbent assay , the auto-antibodies were found to be reactive to desmoglein 1 antigen. Various clinical, histopathological, and immunological findings in our case overlapped with the features of IgA pemphigus, pemphigus herpetiformis, and pemphigus foliaceus. These findings indicate that IgG/IgA pemphigus may be a transitional form between IgA pemphigus and pemphigus herpetiformis, and thus provides insight into the pathogenicity of this rare disorder.


Subject(s)
Dapsone/administration & dosage , Desmoglein 1/analysis , Desmoglein 1/metabolism , Humans , Immunoglobulin A/analysis , /analysis , Male , Pemphigus/classification , Pemphigus/drug therapy , Pemphigus/immunology , Pemphigus/pathology , Skin Diseases/immunology , Skin Diseases/pathology
3.
Indian J Dermatol Venereol Leprol ; 2013 Jul-Aug; 79(4): 539-541
Article in English | IMSEAR | ID: sea-147511
5.
Indian J Dermatol Venereol Leprol ; 2012 Jan-Feb; 78(1): 111-113
Article in English | IMSEAR | ID: sea-141013
6.
Indian J Dermatol Venereol Leprol ; 2010 May-Jun; 76(3): 305-306
Article in English | IMSEAR | ID: sea-140627
7.
Article in English | IMSEAR | ID: sea-88461

ABSTRACT

Cytomegalovirus (CMV) is an important cause of morbidity and mortality in immunosuppressed patients. Though acute lymphoblastic leukemia (ALL) is an immunosuppressed state, CMV disease has been reported infrequently. We present a patient of adult B lineage ALL who was on maintenance chemotherapy and developed CMV pneumonia. Patient was managed with intravenous ganciclovir and had successful outcome. However, three weeks later patient had a relapse of ALL and died shortly after high dose chemotherapy.


Subject(s)
Adolescent , Antiviral Agents/therapeutic use , Cytomegalovirus Infections/diagnosis , Ganciclovir/therapeutic use , Humans , Immunosuppression Therapy , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL